How valuable is prostate-specific antigen screening?
作者信息
Handler S
出版信息
Minn Med. 1996 Jun;79(6):2.
PMID:8692130
Abstract
摘要
相似文献
1
How valuable is prostate-specific antigen screening?
Minn Med. 1996 Jun;79(6):2.
2
Does screening with prostate/specific antigen improve outcomes?
Minn Med. 1996 Apr;79(4):50-1.
3
Prostate cancer: enthusiasm for screening.
Med J Aust. 1995 May 15;162(10):540-1.
4
Re: The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years?
J Urol. 2005 Sep;174(3):1154-5; author reply 1155-6. doi: 10.1097/01.ju.0000169211.49050.8f.
5
PSA screening: the bottom line.
CMAJ. 2000 Mar 21;162(6):791-2.
6
Why PSA testing does have value.
Practitioner. 1997 Jul;241(1576):363.
7
Screening by the prostate-specific antigen test: what do the patients know?
J Cancer Educ. 1996 Spring;11(1):39-44. doi: 10.1080/08858199609528390.
8
Best screening tests for prostate cancer.
West J Med. 1998 Aug;169(2):109-10.
9
Controversy over prostate-specific antigen screening has shifted from mortality to overtreatment issues.
Int J Urol. 2009 Sep;16(9):711-12.
10
[Mass screening for prostate cancer in Nagano].
Hinyokika Kiyo. 2001 Nov;47(11):769-72.
Zotero 插件